法尼醇X受体对代谢调控作用的研究进展

被引:14
作者
颜勇 [1 ]
李旭忠 [2 ]
周舟 [3 ]
胡承 [3 ]
张学利 [1 ]
机构
[1] 上海, 南方医科大学附属奉贤区中心医院普外科
[2] 苏州大学临床医学院
[3] 上海交通大学附属第六人民医院内分泌代谢科上海市糖尿病研究所
关键词
D O I
暂无
中图分类号
R58 [内分泌腺疾病及代谢病];
学科分类号
100201 [内科学];
摘要
<正>
引用
收藏
相关论文
共 29 条
[1]
Farnesoid X receptor–induced lysine‐specific histone demethylase reduces hepatic bile acid levels and protects the liver against bile acid toxicity.[J].Young‐Chae Kim;Sungsoon Fang;Sangwon Byun;Sunmi Seok;Byron Kemper;Jongsook Kim Kemper.Hepatology.2015, 1
[2]
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial [J].
Neuschwander-Tetri, Brent A. ;
Loomba, Rohit ;
Sanyal, Arun J. ;
Lavine, Joel E. ;
Van Natta, Mark L. ;
Abdelmalek, Manal F. ;
Chalasani, Naga ;
Dasarathy, Srinivasan ;
Diehl, Anna Mae ;
Hameed, Bilal ;
Kowdley, Kris V. ;
McCullough, Arthur ;
Terrault, Norah ;
Clark, Jeanne M. ;
Tonascia, James ;
Brunt, Elizabeth M. ;
Kleiner, David E. ;
Doo, Edward .
LANCET, 2015, 385 (9972) :956-965
[3]
Recent advances in the development of farnesoid X receptor agonists [J].
Ali, Ahmad H. ;
Carey, Elizabeth J. ;
Lindor, Keith D. .
ANNALS OF TRANSLATIONAL MEDICINE, 2015, 3 (01)
[4]
Glucose Sensing O-GlcNAcylation Pathway Regulates the Nuclear Bile Acid Receptor Farnesoid X Receptor (FXR) [J].
Berrabah, Wahiba ;
Aumercier, Pierrette ;
Gheeraert, Celine ;
Dehondt, Helene ;
Bouchaert, Emmanuel ;
Alexandre, Jeremy ;
Ploton, Maheul ;
Mazuy, Claire ;
Caron, Sandrine ;
Tailleux, Anne ;
Eeckhoute, Jerome ;
Lefebvre, Tony ;
Staels, Bart ;
Lefebvre, Philippe .
HEPATOLOGY, 2014, 59 (05) :2022-2033
[5]
Efficacy and Safety of the Farnesoid X Receptor Agonist Obeticholic Acid in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease [J].
Mudaliar, Sunder ;
Henry, Robert R. ;
Sanyal, Arun J. ;
Morrow, Linda ;
Marschall, Hanns-Ulrich ;
Kipnes, Mark ;
Adorini, Luciano ;
Sciacca, Cathi I. ;
Clopton, Paul ;
Castelloe, Erin ;
Dillon, Paul ;
Pruzanski, Mark ;
Shapiro, David .
GASTROENTEROLOGY, 2013, 145 (03) :574-+
[6]
Synthetic FXR Agonist GW4064 Prevents Diet-Induced Hepatic Steatosis and Insulin Resistance [J].
Ma, Yongjie ;
Huang, Yixian ;
Yan, Linna ;
Gao, Mingming ;
Liu, Dexi .
PHARMACEUTICAL RESEARCH, 2013, 30 (05) :1447-1457
[7]
Farnesoid X receptor targeting to treat nonalcoholic steatohepatitis.[J].Luciano Adorini;Mark Pruzanski;David Shapiro.Drug Discovery Today.2012, 17-1
[8]
Farnesoid X Receptor Induces Murine Scavenger Receptor Class B Type I via Intron Binding [J].
Li, Guodong ;
Thomas, Ann M. ;
Williams, Jessica A. ;
Kong, Bo ;
Liu, Jie ;
Inaba, Yuka ;
Xie, Wen ;
Guo, Grace L. .
PLOS ONE, 2012, 7 (04)
[9]
Selective Activation of Nuclear Bile Acid Receptor FXR in the Intestine Protects Mice Against Cholestasis [J].
Modica, Salvatore ;
Petruzzelli, Michele ;
Bellafante, Elena ;
Murzilli, Stefania ;
Salvatore, Lorena ;
Celli, Nicola ;
Di Tullio, Giuseppe ;
Palasciano, Giuseppe ;
Moustafa, Tarek ;
Halilbasic, Emina ;
Trauner, Michael ;
Moschetta, Antonio .
GASTROENTEROLOGY, 2012, 142 (02) :355-U269
[10]
糖尿病与非酒精性脂肪性肝病 [J].
范竹萍 ;
赵雄 .
中华糖尿病杂志, 2009, 1 (04)